Prakash et al., 2008 - Google Patents
Serum paraoxonase activity and protein thiols in chronic renal failure patientsPrakash et al., 2008
View HTML- Document ID
- 3839407437366595919
- Author
- Prakash M
- Shetty J
- Rao L
- Sharma S
- Rodrigues A
- Prabhu R
- Publication year
- Publication venue
- Indian Journal of Nephrology
External Links
Snippet
Serum paraoxonase is known to prevent low-density lipoprotein oxidation and atherogenesis. Association of paraoxonase with the oxidative status and lipid profile in chronic renal failure (CRF) patients on conservative management and those on chronic …
- 102000006996 Aryldialkylphosphatase 0 title abstract description 62
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Houshang et al. | Antioxidant status in patients with psoriasis | |
| Ferretti et al. | Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients | |
| Santi et al. | Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism | |
| Kural et al. | The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant–antioxidant system in patients with dyslipidemia | |
| Milionis et al. | Lipoprotein (a) and stroke | |
| Mackness et al. | Paraoxonase 1 activity, concentration and genotype in cardiovascular disease | |
| Mackness et al. | Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls | |
| James et al. | Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease | |
| Gugliucci et al. | Paraoxonase 1 in chronic kidney failure | |
| Ferretti et al. | HDL‐paraoxonase and Membrane Lipid Peroxidation: A comparison between healthy and obese subjects | |
| Fuhrman et al. | Paraoxonase 1 (PON1) is present in postprandial chylomicrons | |
| Kane et al. | Prebeta-1 HDL and coronary heart disease | |
| Marais et al. | Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E | |
| Gauthier et al. | Freshly isolated bovine coronary endothelial cells do not express the BKCa channel gene | |
| Meroño et al. | High risk of cardiovascular disease in iron overload patients | |
| Viswanathan et al. | Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy | |
| Anderson et al. | Phenolsulphotransferase: enzyme activity and endogenous inhibitors in the human erythrocyte. | |
| Prakash et al. | Serum paraoxonase activity and protein thiols in chronic renal failure patients | |
| Vilar-Gomez et al. | The protection conferred by HSD17B13 rs72613567 polymorphism on risk of steatohepatitis and fibrosis may be limited to selected subgroups of patients with NAFLD | |
| Stibler et al. | Complex functional and structural coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome type I | |
| Suvarna et al. | Paraoxonase activity in type 2 diabetes mellitus patients with and without complications | |
| Bayrak et al. | The effect of HDL-bound and free PON1 on copper-induced LDL oxidation | |
| Kolagal et al. | Determination of oxidative stress markers and their importance in early diagnosis of uremia-related complications | |
| Kedage et al. | Serum paraoxonase 1 activity status in patients with liver disorders | |
| Unal et al. | Serum paraoxonase (a high-density lipoprotein-associated lipophilic antioxidant) activity and lipid profile in experimental acute pancreatitis |